Department of Health and Human Services: New National Institutes of Health program provides comprehensive treatment for inherited blood and immune diseases
People with inherited diseases of the blood and immune system can now receive treatment at the National Institutes of Health Clinical Center through a new, streamlined program that integrates expertise from many medical specialties and related basic science disciplines. Immunologists, transplant specialists, geneticists and hematologists from across NIH are collaborating in the Blood and Immune Deficiency-Cellular Therapy Program (BID-CTP). These physicians will deliver state-of-the-art and experimental care to people with rare blood and immune system diseases through a unified approach to assessing, treating and monitoring patients and the centralized tracking of treatment outcomes. The initiative spans four NIH institutes: the